No difference seen in number of ventilator-free days, time to extubation, reintubation with PSV versus T-piece<\/p>\n<\/h3>\n
<\/b><\/p>\n
<\/b><\/p>\n
THURSDAY, Oct. 27, 2022 (HealthDay News) — For patients at high risk for extubation failure, the number of ventilator-free days at day 28 is no different for spontaneous-breathing trials performed with use of pressure-support ventilation (PSV) or a T-piece, according to a study published online Oct. 26 in the New England Journal of Medicine<\/em> to coincide with LIVES 2022, the annual congress of the European Society of Intensive Care Medicine, held from Oct. 22 to 26 in Paris.<\/p>\n Arnaud W. Thille, M.D., Ph.D., from Centre Hospitalier Universitaire de Poitiers in France, and colleagues randomly assigned patients with a high risk for extubation failure to undergo spontaneous-breathing trials performed with use of PSV or a T-piece. The analysis included 969 patients (484 in the PSV group and 485 in the T-piece group).<\/p>\n The researchers found that the median number of ventilator-free days was 27 in both the PSV and T-piece groups at day 28. Extubation was performed within 24 hours in 77.7 and 72.2 percent of patients in the PSV and T-piece groups, respectively; extubation was performed within seven days in 97.7 and 94.4 percent of patients, respectively. Reintubation was performed in 14.9 and 13.6 percent of patients in the PSV and T-piece groups, respectively. In nine patients (three in the PSV group and six in the T-piece group), cardiac or respiratory arrest was a reason for reintubation.<\/p>\n “Our primary analysis showed no significant difference between these two strategies with respect to the number of ventilator-free days after the initial spontaneous-breathing trial,” the authors write.<\/p>\n Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n Editorial (subscription or payment maybe required)<\/a><\/p>\n